Characteristics of stromal components of proliferative, up to 10 mm leiomyomas - extracellular matrix, angiogenesis and fibrosis according to nodule size in perimenopausal patients

Characteristics of stromal components of proliferative, up to 10 mm leiomyomas - extracellular matrix, angiogenesis and fibrosis according to nodule size in perimenopausal patients

Authors

DOI:

https://doi.org/10.52340/spectri.2024.09.01.14

Abstract

As it is known, the formation of leiomyoma is related to the violation of the synthesis of sex steroid hormones, genetic abnormalities and wound healing disorders. In the development of leiomyoma, the role of growth factors involved in the formation of the extracellular matrix is ​​discussed, these factors also play a role in impaired wound healing, which can then lead to tumorigenesis.

Based on the fact that the risks of leiomyoma development exist in perimenopause, the aim of our research is to identify the characteristics of stromal components - extracellular matrix, angiogenesis and fibrosis in the proliferative, small-growing, up to 10mm leiomyomas in preparations stained with hematoxylin and eosin and Masson's trichrome according to the size of the nodes.

Conclusion: 1. Proliferative, small-growing, active and remodeled (mainly deformed blood vessels, capillaries and arterioles) angiogenesis detected in nodules up to 10 mm gives us a reason to express an opinion about their mandatory role in the process of growth and development of leiomyoma during perimenopause.

  1. Premenopause is characterized by the process of active growth and development of nodes with activation of stromal components, an increase in the volume of the extracellular matrix and the characteristics of fibrosis, while in menopause and postmenopause the mentioned process is delayed and takes on a prolonged asymptomatic character.

Downloads

Download data is not yet available.

Author Biographies

Guranda Bakradze, David Agmashenebeli University of Georgia

დოქტორანტი

Marina Failodze, Tbilisi State Medical University

ასისტენტ პროფესორი

Nata Firtskhalava, David Agmashenebeli University of Georgia

ასოცირებული პროფესორი

Ketevan Jangveladze, Tbilisi State Medical University

ასისტენტ პროფესორი

References

Asada H, et al. Potential link between estrogen receptor-alpha gene hypomethylation and uterine fibroid formation. Mol Hum Reprod. 2008;14(9):539–545

Andersen A, Barbieri RL. Abnormal gene expression in uterine leiomyomas. J Soc Gynecol Invest. 1995;2(5):663–672.

Arslan AA, et al. Gene expression studies provide clues to the pathogenesis of uterine leiomyoma: new evidence and a systematic review. Hum Reprod. 2005;20(4):852–863.

Chegini N. Proinflammatory and profibrotic mediators: principal effectors of leiomyoma development as a fibrotic disorder. Semin Reprod Med. 2010;28(3):180–203.

Cramer SF,Patel A.The frequency of uterine leiomyom.Am J Clin Pathol.1990;94:435–438.

Flake GP, Andersen J, Dixon D. Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect. 2003;111(8):1037–1054.

Leppert PC, Catherino WH, Segars JH. A new hypothesis about the origin of uterine fibroids based on gene expression profiling with microarrays. Am J Obstet Gynecol. 2006;195(2):415–420.

Malik M, et al. Why leiomyomas are called fibroids: the central role of extracellular matrix in symptomatic women. Semin Reprod Med. 2010;28(3):169–179.

Peddada SD, et al. Growth of uterine leiomyomata among premenopausal black and white women. Proc Natl Acad Sci U S A. 2008;105(50):19887–19892.

Downloads

Published

2024-11-15

How to Cite

Bakradze, G., Failodze, M., Firtskhalava, N., Jangveladze, K., & Chovelidze, G. (2024). Characteristics of stromal components of proliferative, up to 10 mm leiomyomas - extracellular matrix, angiogenesis and fibrosis according to nodule size in perimenopausal patients. Scientific Journal „Spectri“, 9(1). https://doi.org/10.52340/spectri.2024.09.01.14

Issue

Section

Articles
Loading...